University of Missouri

The Surprising Reach of FDA Regulation of Cannabis, Even after Descheduling

69 AMERICAN UNIVERSITY LAW REVIEW 823 (2019).

Access Before Evidence and the Price of FDA’s New Drug Authorities

53 UNIVERSITY OF RICHMOND LAW REVIEW 1243 (2019).

The Drug Innovation Paradox

83 MISSOURI LAW REVIEW 39 (2018).

A Solution in Search of a Problem at the Biologics Frontier

2018 UNIVERSITY OF ILLINOIS LAW REVIEW ONLINE 19 (2018).

Paper Promises for Drug Innovation

26 GEORGE MASON LAW REVIEW 168 (2018).

The History and Political Economy of the Hatch-Waxman Amendments

49 SETON HALL LAW REVIEW 53 (2018).

The Uncharted Waters of Competition and Innovation in Biological Medicines

44 FLORIDA STATE UNIVERSITY LAW REVIEW 883 (2017).

Antitrust Abuses and the FDA Approval Process: Statement Before the Committee on the Judiciary’s Subcommittee on Regulatory Reform, Commercial, and Antitrust Law U.S. House of Representatives

The Law of 180-Day Exclusivity

71 FOOD AND DRUG LAW JOURNAL 327 (2016).

A Second Look at the CREATES Act: What’s Not Being Said

17 FEDERALIST SOCIETY REVIEW 28 (2016).